Literature DB >> 29018516

Is There a Future for Remote Cardiac Implantable Electronic Device Management?

Haran Burri1.   

Abstract

In the era of communication technology, remote monitoring has been a paradigm shift in the way patients with cardiac implantable electronic devices are managed. It has been endorsed by scientific societies and is being increasingly adopted in the clinical setting. Despite the various advantages associated with this strategy, data on improved clinical outcome are still sparse. The recently published study on the remote management of heart failure using implanted devices and formalised follow-up procedures, which turned out to be negative, has cast doubt on whether remote monitoring should still be used. This article provides a critical appraisal of the study, and discusses the issue of remote data management.

Entities:  

Keywords:  Remote monitoring; cardiac implantable electronic devices; cardiac resynchronisation therapy; implantable cardioverter defibrillator

Year:  2017        PMID: 29018516      PMCID: PMC5610739          DOI: 10.15420/aer.2017:10:1

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN: 2050-3369


  21 in total

1.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

2.  Remote monitoring: a cost or an investment?

Authors:  Haran Burri; Hein Heidbüchel; Werner Jung; Pedro Brugada
Journal:  Europace       Date:  2011-05       Impact factor: 5.214

3.  Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

Authors:  Niraj Varma; Andrew E Epstein; Anand Irimpen; Robert Schweikert; Charles Love
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

4.  Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT device Trial (CLEPSYDRA) study.

Authors:  Angelo Auricchio; Michael R Gold; Josep Brugada; G Nölker; Siva Arunasalam; Christophe Leclercq; Pascal Defaye; Leonardo Calò; Oliver Baumann; Francisco Leyva
Journal:  Eur J Heart Fail       Date:  2014-03-17       Impact factor: 15.534

5.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.

Authors:  George H Crossley; Andrew Boyle; Holly Vitense; Yanping Chang; R Hardwin Mead
Journal:  J Am Coll Cardiol       Date:  2011-01-20       Impact factor: 24.094

6.  Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.

Authors:  Niraj Varma; Justin Michalski; Andrew E Epstein; Robert Schweikert
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-08-17

7.  Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients.

Authors:  Alan Cheng; Sean R Landman; Robert W Stadler
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-08-26

8.  The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring.

Authors:  Giuseppe Boriani; Antoine Da Costa; Renato Pietro Ricci; Aurelio Quesada; Stefano Favale; Saverio Iacopino; Francesco Romeo; Arnaldo Risi; Lorenza Mangoni di S Stefano; Xavier Navarro; Mauro Biffi; Massimo Santini; Haran Burri
Journal:  J Med Internet Res       Date:  2013-08-21       Impact factor: 5.428

9.  Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting.

Authors:  Martin R Cowie; Shantanu Sarkar; Jodi Koehler; David J Whellan; George H Crossley; Wai Hong Wilson Tang; William T Abraham; Vinod Sharma; Massimo Santini
Journal:  Eur Heart J       Date:  2013-03-19       Impact factor: 29.983

10.  Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations.

Authors:  Niraj Varma; Justin Michalski; Bruce Stambler; Behzad B Pavri
Journal:  Eur Heart J       Date:  2014-03-03       Impact factor: 29.983

View more
  2 in total

1.  Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?

Authors:  Frieder Braunschweig; Stefan D Anker; Jochen Proff; Niraj Varma
Journal:  Europace       Date:  2019-06-01       Impact factor: 5.214

2.  Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial.

Authors:  Johann Christoph Geller; Thorsten Lewalter; Niels Eske Bruun; Milos Taborsky; Frank Bode; Jens Cosedis Nielsen; Christoph Stellbrink; Steffen Schön; Holger Mühling; Hanno Oswald; Sebastian Reif; Stefan Kääb; Peter Illes; Jochen Proff; Nikolaos Dagres; Gerhard Hindricks
Journal:  Clin Res Cardiol       Date:  2019-03-14       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.